Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Europeans Clear Instrumentation Deal

by Marc S. Reisch
December 2, 2013 | A version of this story appeared in Volume 91, Issue 48

The European Commission has cleared Thermo Fisher Scientific’s pending $13.6 billion acquisition of instrumentation and life sciences industry supplier Life Technologies. As a condition for approval, Thermo Fisher agreed to divest its cell culture, gene modulation, and magnetic beads businesses, which had combined sales of $225 million last year. Other approvals are still pending, including one from U.S. regulators. Thermo Fisher says it doesn’t expect the U.S. will require additional divestitures, and it still expects the deal will close in early 2014.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.